Nanangenine F

Nanangenine F is a drimane sesquiterpenoid with weak antibacterial and anticancer activities. Nanangenine F inhibits Bacillus subtilis (ATCC 6633) with an IC50 of 78 µg/mL. Nanangenine F inhibits NS-1, DU-145, MCF-7 and human fibroblast NFF cells with IC50s of 49 µg/mL, 95 µg/mL, 49 µg/mL, and 84 µg/mL, respectively[1].

Product Specifications

UNSPSC

12352211

Target

Bacterial

Related Pathways

Anti-infection

Field of Research

Cancer; Infection

Smiles

CC1(CC[C@H]([C@]2([C@]1([C@@H](C=C([C@@]2(C=O)O)C)OC(CCCCC)=O)[H])C)O)C

Molecular Formula

C21H34O5

Molecular Weight

366.49

References & Citations

[1]Lacey HJ, et al. Nanangenines: drimane sesquiterpenoids as the dominant metabolite cohort of a novel Australian fungus, Aspergillus nanangensis. Beilstein J Org Chem. 2019 Nov 5;15:2631-2643.